Jazz Pharmaceuticals Announces Second Quarter 2017 Financial Results

Go back to Jazz Pharmaceuticals Announces Second Quarter 2017 Financial Results
JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) Delayed: 225.92 --0 (-0%)
Previous Close $225.92    52 Week High $160.00 
Open $225.92    52 Week Low $95.80 
Day High $225.92    P/E 41.99 
Day Low $225.92    EPS $5.38 
Volume 57